Outcomes of Cancer Patients Undergoing Transcatheter Aortic Valve Replacement.

Authors

Vardhmaan Jain
Anas M Saad
Mohamed M Gad
Agam Bansal
Omar Abdelfattah
Medhat Farwati
Keerat R. Ahuja, Division of Cardiovascular Medicine, Reading Hospital-Tower Health, West Reading, PAFollow
James Yun
Amar Krishnaswamy
Samir R Kapadia, Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue, J2-3, Cleveland, Ohio

Document Type

Letter to the Editor

Publication Date

9-1-2020

Publication Title

JACC CardioOncol

Volume

2

Issue

3

First Page

506

Last Page

508

Comments

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Jain, V., Saad, A., Gad, M., Bansal, A., Abdelfattah, O., Farwati, M., Ahuja, K. R., Yun, J., Krishnaswamy, A., & Kapadia, S. (2020). Outcomes of Cancer Patients Undergoing Transcatheter Aortic Valve Replacement.. JACC CardioOncol, 2 (3), 506-508. https://doi.org/DOI: 10.1016/j.jaccao.2020.05.023